ELMO1 and Dock180, a bipartite Rac1 guanine nucleotide exchange factor, promote human glioma cell invasion

Cancer Research

Volumn 67, Issue 15, 2007, Pages 7203-7211

  Jarzynka, Michael J ^a,b   Hu, Bo ^a,b   Hui, Kwok Min ^a,b   Bar Joseph, Ifat ^a,b   Gu, Weisong ^c,f   Hirose, Takanori ^d   Haney, Lisa B ^e   Ravichandran, Kodi S ^e   Nishikawa, Ryo ^d   Cheng, Shi Yuan ^a,b  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c Ohio Supercomputer Center (Springfield)   (United States)

^d SAITAMA MEDICAL UNIVERSITY   (Japan)

^e UNIVERSITY OF VIRGINIA   (United States)

^f SuperArray Bioscience Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; DOCK180 BINDING PROTEIN; ELMO1 BINDING PROTEIN; GUANINE NUCLEOTIDE EXCHANGE FACTOR; RAC1 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN SLICE; BRAIN TISSUE; CANCER CELL; CANCER CELL CULTURE; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CONTROLLED STUDY; CYTOKINESIS; ENZYME INHIBITION; GLIOMA; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MICRODISSECTION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; BRAIN NEOPLASMS; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; GLIOMA; HUMANS; IMMUNOBLOTTING; MICE; MICE, INBRED C57BL; NEOPLASM INVASIVENESS; PLASMIDS; RAC GTP-BINDING PROTEINS; RAC1 GTP-BINDING PROTEIN; TRANSFECTION;

EID: 34547616112     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-07-0473     Document Type: Article

References (44)

1. Maher EA, Furnari FB, Bachoo RM, et al. Malignant glioma: genetics and biology of a grave matter. Genes Dev 2001;15:1311-33.
2. Giese A, Bjerkvig R, Berens ME, Westphal M. Cost of migration: invasion of malignant gliomas and implications for treatment. J Clin Oncol 2003;21:1624-36.
3. Etienne-Manneville S, Hall A. Rho GTPases in cell biology. Nature 2002;420:629-35.
4. Servotte S, Camby I, Debeir O, et al. The in vitro influences of neurotensin on the motility characteristics of human U373 glioblastoma cells. Neuropathol Appl Neurobiol 2006;32:575-84.
5. Tran NL, McDonough WS, Savitch BA, et al. Increased fibroblast growth factor-inducible 14 expression levels promote glioma cell invasion via Rac1 and nuclear factor-κB and correlate with poor patient outcome. Cancer Res 2006;66:9535-42.
6. Chan AY, Coniglio SJ, Chuang YY, et al. Roles of the Rac1 and Rac3 GTPases in human tumor cell invasion. Oncogene 2005;24:7821-9.
7. Salhia B, Rutten F, Nakada M, et al. Inhibition of Rhokinase affects astrocytoma morphology, motility, and invasion through activation of Rac1. Cancer Res 2005;65:8792-800.
8. Murai T, Miyazaki Y, Nishinakamura H, et al. Engagement of CD44 promotes Rac activation and CD44 cleavage during tumor cell migration. J Biol Chem 2004;279:4541-50.
9. Nakada M, Drake KL, Nakada S, Niska JA, Berens ME. Ephrin-B3 ligand promotes glioma invasion through activation of Rac1. Cancer Res 2006;66:8492-500.
10. Valster A, Tran NL, Nakada M, et al. Cell migration and invasion assays. Methods 2005;37:208-15.
11. Raftopoulou M, Hall A. Cell migration: Rho GTPases lead the way. Dev Biol 2004;265:23-32.
12. Hall A. Rho GTPases and the control of cell behaviour. Biochem Soc Trans 2005;33:891-5.
13. Meller N, Merlot S, Guda C. CZH proteins: a new family of Rho-GEFs. J Cell Sci 2005;118:4937-46.
14. Hasegawa H, Kiyokawa E, Tanaka S, et al. DOCK180, a major CRK-binding protein, alters cell morphology upon translocation to the cell membrane. Mol Cell Biol 1996;16:1770-6.
15. Kiyokawa E, Hashimoto Y, Kobayashi S, et al. Activation of Rac1 by a Crk SH3-binding protein, DOCK180. Genes Dev 1998;12:3331-6.
16. Erickson MR, Galletta BJ, Abmayr SM. Drosophila myoblast city encodes a conserved protein that is essential for myoblast fusion, dorsal closure, and cytoskeletal organization. J Cell Biol 1997;138:589-603.
17. Nolan KM, Barrett K, Lu Y, et al. Myoblast city, the Drosophila homolog of DOCK180/CED-5, is required in a Rac signaling pathway utilized for multiple developmental processes. Genes Dev 1998;12:3337-42.
18. Wu YC, Horvitz HR. C. elegans phagocytosis and cell-migration protein CED-5 is similar to human DOCK180. Nature 1998;392:501-4.
19. Albert ML, Kim JI, Birge RB. αvβ5 integrin recruits the CrkII-Dock180-1 complex for phagocytosis of apoptotic cells. Nat Cell Biol 2000;2:899-905.
20. Gustavsson A, Yuan M, Fallman M. Temporal dissection of β1-integrin signaling indicates a role for p130Cas-Crk in filopodia formation. J Biol Chem 2004;279:22893-901.
21. Brugnera E, Haney L, Grimsley C, et al. Unconventional Rac-GEF activity is mediated through the Dock180-ELMO complex. Nat Cell Biol 2002;4:574-82.
22. Cote JF, Vuori K. Identification of an evolutionarily conserved superfamily of DOCK180-related proteins with guanine nucleotide exchange activity. J Cell Sci 2002;115:4901-13.
23. Cote JF, Vuori K. In vitro guanine nucleotide exchange activity of DHR-2/DOCKER/CZH2 domains. Methods Enzymol 2006;406:41-57.
24. Gumienny TL, Brugnera E, Tosello-Trampont AC, et al. CED-12/ELMO, a novel member of the CrkII/Dock180/Rac pathway, is required for phagocytosis and cell migration. Cell 2001;107:27-41.
25. Grimsley CM, Kinchen JM, Tosello-Trampont AC, et al. Dock180 and ELMO1 proteins cooperate to promote evolutionarily conserved Rac-dependent cell migration. J Biol Chem 2004;279:6087-97.
26. Furnari FB, Lin H, Huang HS, Cavenee WK. Growth suppression of glioma cells by PTEN requires a functional phosphatase catalytic domain. Proc Natl Acad Sci U S A 1997;94:12479-84.
27. Sonoda Y, Ozawa T, Hirose Y, et al. Formation of intracranial tumors by genetically modified human astrocytes defines four pathways critical in the development of human anaplastic astrocytoma. Cancer Res 2001;61:4956-60.
28. Guo P, Imanishi Y, Cackowski FC, et al. Up-regulation of angiopoietin-2, matrix metalloprotease-2, membrane type 1 metalloprotease, and laminin 5γ2 correlates with the invasiveness of human glioma. Am J Pathol 2005;166:877-90.
29. Makino Y, Tsuda M, Ichihara S, et al. Elmo1 inhibits ubiquitylation of Dock180. J Cell Sci 2006;119:923-32.
30. Janardhan A, Swigut T, Hill B, Myers MP, Skowronski J. HIV-1 Nef binds the DOCK2-1 complex to activate rac and inhibit lymphocyte chemotaxis. PLoS Biol 2004;2:E6.
31. Hu B, Guo P, Fang Q, et al. Angiopoietin-2 induces human glioma invasion through the activation of matrix metalloprotease-2. Proc Natl Acad Sci U S A 2003;100:8904-9.
32. Demuth T, Berens ME. Molecular mechanisms of glioma cell migration and invasion. J Neurooncol 2004;70:217-28.
33. Kleihues P, Cavenee WK; International Agency for Research on Cancer. Pathology and genetics of tumours of the nervous system. Lyon: IARC Press; 2000. p. 314.
34. Sahai E. Mechanisms of cancer cell invasion. Curr Opin Genet Dev 2005;15:87-96.
35. Christofori G. New signals from the invasive front. Nature 2006;441:444-50.
36. Hamel W, Westphal M. Growth factors in gliomas revisited. Acta Neurochir (Wien) 2000;142:113-37; discussion 37-8.
37. Bachoo RM, Maher EA, Ligon KL, et al. Epidermal growth factor receptor and Ink4a/Arf: convergent mechanisms governing terminal differentiation and transformation along the neural stem cell to astrocyte axis. Cancer Cell 2002;1:269-77.
38. Wei Q, Clarke L, Scheidenhelm DK, et al. High-grade glioma formation results from postnatal Pten loss or mutant epidermal growth factor receptor expression in a transgenic mouse glioma model. Cancer Res 2006;66:7429-37.
39. McDonough WS, Tran NL, Berens ME. Regulation of glioma cell migration by serine-phosphorylated P311. Neoplasia 2005;7:862-72.
40. Rossman KL, Der CJ, Sondek J. GEF means go: turning on RHO GTPases with guanine nucleotide-exchange factors. Nat Rev Mol Cell Biol 2005;6:167-80.
41. Bellail AC, Hunter SB, Brat DJ, Tan C, Van Meir EG. Microregional extracellular matrix heterogeneity in brain modulates glioma cell invasion. Int J Biochem Cell Biol 2004;36:1046-69.
42. Giese A, Rief M, Loo M, Berens M. Determinants of human astrocytoma migration. Cancer Res 1994;54:3897-904.
43. Rao JS. Molecular mechanisms of glioma invasiveness: the role of proteases. Nat Rev Cancer 2003;3:489-501.
44. Katoh H, Negishi M. RhoG activates Rac1 by direct interaction with the Dock180-binding protein Elmo. Nature 2003;424:461-4.